Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_assertion description "[XRCC3 241 MetMet is an independent determinant of favorable survival in NSCLC patients treated with cisplatin/gemcitabine. A simple molecular assay to determine the XRCC3 241 genotype can be useful for customizing chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_assertion evidence source_evidence_literature NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_assertion SIO_000772 16407418 NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_assertion wasDerivedFrom gad-20150221 NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_assertion wasGeneratedBy ECO_0000203 NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.
- gad-20150221 importedOn "2015-02-21" NP98442.RAsAR7k-QCqlhZmfjGJGPmq6dcJMJEF1jpi4gQrjDB-8I130_provenance.